Phathom Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 12.47 M | $146.73 M | 0.00% | 17.20% |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 10/17/2025 | 7.46 M | $87.86 M | 0.00% | 10.30% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 5.08 M | $59.81 M | 125.79% | 7.01% |
| INVESCO LTD. | 11/13/2025 | 3.86 M | $45.49 M | -6.64% | 5.33% |
| CARLYLE GROUP INC. | 11/07/2025 | 3.50 M | $41.05 M | 0.00% | 4.83% |
| BLACKROCK, INC. | 11/12/2025 | 3.40 M | $40.05 M | 2.62% | 4.70% |
| VANGUARD GROUP INC | 11/07/2025 | 3.22 M | $37.85 M | 15.36% | 4.44% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 2.50 M | $29.46 M | -0.66% | 3.45% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2025 | 1.96 M | $23.07 M | 0.00% | 2.70% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 1.82 M | $21.43 M | -13.52% | 2.51% |
| WASATCH ADVISORS LP | 11/14/2025 | 1.54 M | $18.09 M | 5.15% | 2.12% |
| CATALYS PACIFIC, LLC | 11/14/2025 | 1.17 M | $13.74 M | 0.00% | 1.61% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/12/2025 | 1.14 M | $13.47 M | 9.14% | 1.58% |
| CATALIO CAPITAL MANAGEMENT, LP | 11/14/2025 | 1.13 M | $13.28 M | 67.86% | 1.56% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.09 M | $12.82 M | 1.77% | 1.50% |
| STATE STREET CORP | 11/14/2025 | 1.05 M | $12.40 M | 24.04% | 1.45% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 1.00 M | $11.77 M | 163.09% | 1.38% |
| MOORE CAPITAL MANAGEMENT, LP | 11/14/2025 | 600.00 K | $7.06 M | 0.00% | 0.83% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 554.59 K | $6.53 M | 206.66% | 0.77% |
| PROPEL BIO MANAGEMENT, LLC | 11/12/2025 | 552.93 K | $6.51 M | -40.09% | 0.76% |
| CITADEL ADVISORS LLC | 11/14/2025 | 508.72 K | $5.99 M | 100.00% | 0.70% |
| AIGH CAPITAL MANAGEMENT LLC | 10/31/2025 | 429.00 K | $5.05 M | 100.00% | 0.59% |
| STEPSTONE GROUP LP | 11/14/2025 | 422.09 K | $4.97 M | 0.00% | 0.58% |
| SUMMITTX CAPITAL, L.P. | 11/14/2025 | 385.97 K | $4.54 M | 100.00% | 0.53% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 365.90 K | $4.31 M | 1.59% | 0.50% |
| NORTHERN TRUST CORP | 11/14/2025 | 357.58 K | $4.21 M | -0.49% | 0.49% |
| UBS GROUP AG | 11/13/2025 | 338.36 K | $3.98 M | -19.34% | 0.47% |
| SIMPLIFY ASSET MANAGEMENT INC. | 10/20/2025 | 321.94 K | $3.79 M | -38.32% | 0.44% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2025 | 306.00 K | $3.60 M | -71.25% | 0.42% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 295.16 K | $3.47 M | 2,139.12% | 0.41% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 290.47 K | $3.42 M | 100.00% | 0.40% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 267.96 K | $3.15 M | 0.00% | 0.37% |
| MORGAN STANLEY | 11/14/2025 | 255.57 K | $3.01 M | 64.96% | 0.35% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 249.09 K | $2.93 M | 159.26% | 0.34% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 201.52 K | $2.23 M | 100.00% | 0.28% |
| WOODLINE PARTNERS LP | 11/14/2025 | 187.29 K | $2.20 M | 0.00% | 0.26% |
| ROYAL BANK OF CANADA | 11/14/2025 | 162.44 K | $1.91 M | 2.85% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 154.28 K | $1.82 M | 14.95% | 0.21% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 152.03 K | $1.79 M | -21.03% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 146.46 K | $1.72 M | 100.00% | 0.20% |
| JPMORGAN CHASE & CO | 11/26/2025 | 136.95 K | $1.61 M | -1.13% | 0.19% |
| BARCLAYS PLC | 11/12/2025 | 128.36 K | $1.51 M | 56.21% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 127.38 K | $1.50 M | 5.13% | 0.18% |
| NUVEEN, LLC | 11/12/2025 | 110.11 K | $1.30 M | 0.00% | 0.15% |
| JANE STREET GROUP, LLC | 11/14/2025 | 107.26 K | $1.26 M | 100.00% | 0.15% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2025 | 88.54 K | $1.04 M | 182.36% | 0.12% |
| BIRCHVIEW CAPITAL, LP | 11/13/2025 | 85.00 K | $1.00 M | 240.00% | 0.12% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 78.18 K | $920.21 K | 100.00% | 0.11% |
| CREATIVE PLANNING | 11/14/2025 | 78.06 K | $918.74 K | 36.31% | 0.11% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/14/2025 | 71.28 K | $838.91 K | 370.59% | 0.10% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Phathom Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 164 institutional investors and hedge funds held shares of Phathom Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 12.47 M
Medicxi Ventures Management (Jersey) Ltd: 7.46 M
MILLENNIUM MANAGEMENT LLC: 5.08 M
Invesco Ltd.: 3.86 M
Carlyle Group Inc.: 3.5 M
BlackRock, Inc.: 3.4 M
86.02% of Phathom Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 69.33 M shares in the last 24 months. This purchase volume represents approximately $846.56 M in transactions.